Dr Robyn Saw

Senior Lecturer
Surgery, Central Clinical School
Sydney Melanoma Unit

Telephone +61 2 9911 7210

Map

Selected grants

2005

  • Lymphoedema following axillary and groin sentinal node biopsy; Saw R, Thompson J; Cancer Council New South Wales/Research Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Saw, R., Kam, P., Thompson, J. (2007). Isolated locoregional drug infusion for advanced and recurrent limb cancer: indications, techniques and results. Regional Oncotherapies, (pp. 177-191). Greece: Paschalidis Medical Publications.

Journals

  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R., Scolyer, R., Thompson, J. (2014). Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution. Annals of Surgery, 260(1), 149-157. [More Information]
  • Damian, D., Saw, R., Thompson, J. (2014). Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma. Journal of Surgical Oncology, 109(4), 308-313. [More Information]
  • Carlino, M., Gowrishankar, K., Saunders, C., Pupo, G., Snoyman, S., Zhang, X., Saw, R., Becker, T., Kefford, R., Long, G., Rizos, H. (2013). Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition Following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma. Molecular Cancer Therapeutics, 12(7), 1332-1342. [More Information]
  • Harish, V., Bond, J., Scolyer, R., Haydu, L., Saw, R., Quinn, M., Benger, R., Uren, R., Stretch, J., Shannon, K., Thompson, J. (2013). Margins of excision and prognostic factors for cutaneous eyelid melanomas. Journal of Plastic, Reconstructive and Aesthetic Surgery (Print Edition), 66(8), 1066-1073. [More Information]
  • Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013). The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research, 23(1), 61-69. [More Information]
  • Pasquali, S., Haydu, L., Scolyer, R., Winstanley, J., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2013). The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas. Annals of Surgery, 258(1), 152-157. [More Information]
  • Murali, R., Haydu, L., Long, G., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Kefford, R., Thompson, J., Scolyer, R. (2012). Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgical Oncology, 19(6), 1782-1789. [More Information]
  • Spillane, A., Haydu, L., Lee, N., Uren, R., Stretch, J., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2012). Evaluation of Incomplete Sentinel Node Biopsy Procedures and Sentinel Node Positivity Rates as Surgical Quality-Assurance Parameters in Melanoma Patients. Annals of Surgical Oncology, 19(12), 3919-3925. [More Information]
  • Murali, R., Haydu, L., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma. Annals of Surgery, 255(1), 128-133. [More Information]
  • Pasquali, S., Spillane, A., de Wilt, J., McCaffery, K., Rossi, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2012). Surgeons' Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey. Annals of Surgical Oncology, 19(13), 4322-4329. [More Information]
  • Martin, R., Shannon, K., Quinn, M., Saw, R., Spillane, A., Stretch, J., Colman, M., Gao, K., Thompson, J. (2012). The Management of Cervical Lymph Nodes in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 19(12), 3926-3932. [More Information]
  • Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S., Saw, R., Thompson, J. (2012). Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology, 30(21), 2678-2683. [More Information]
  • Damian, D., Saw, R. (2011). Dramatic regression of cutaneous, nodal, and visceral melanoma metastases. Journal Of The American Academy Of Dermatology, 65(3), 665-666. [More Information]
  • Spillane, A., Cheung, B., Stretch, J., Scolyer, R., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2009). Proposed quality standards for regional lymph node dissections in patients with melanoma. Annals of Surgery, 249(3), 473-480. [More Information]
  • Mocellin, S., Thompson, J., Pasquali, S., Montesco, M., Pilati, P., Nitti, D., Saw, R., Scolyer, R., Stretch, J., Rossi, C. (2009). Sentinel Node Status Prediction by Four Statistical Models Results From a Large Bi-Institutional Series (n=1132). Annals of Surgery, 250(6), 964-969. [More Information]
  • Spillane, A., Saw, R., Tucker, M., Byth Wilson, K., Thompson, J. (2008). Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Annals of Surgery, 248(2), 286-293. [More Information]
  • Doubrovsky, A., Scolyer, R., Murali, R., McKenzie, P., Watson, G., Lee, C., McLeod, D., McCarthy, W., Uren, R., Stretch, J., Saw, R., Thompson, J. (2008). Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. Annals of Surgical Oncology, 15(1), 323-332. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Guidelines for imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 877-879. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 847-876. [More Information]
  • Moncrieff, M., Bowen, F., Thompson, J., Saw, R., Shannon, K., Spillane, A., Quinn, M., Stretch, J. (2008). Keystone Flap Reconstruction of Primary Melanoma Excision Defects of the Leg-The End of the Skin Graft. Annals of Surgical Oncology, 15(10), 2867-2873. [More Information]
  • Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Lee, C., McLeod, D., Uren, R., Stretch, J., Saw, R., Thompson, J., Scolyer, R. (2007). Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. American Journal of Clinical Pathology, 127(3), 385. [More Information]
  • van Poll, D., Thompson, J., Colman, M., McKinnon, J., Saw, R., Stretch, J., Scolyer, R., Uren, R. (2005). A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(8), 597-608. [More Information]
  • Thompson, J., Saw, R., Stretch, J. (2005). Current strategies for the surgical management of melanoma. Cancer Forum, 29(2), 81-86.
  • Yee, V., Thompson, J., McKinnon, J., Scolyer, R., Li, L., McCarthy, W., O'Brien, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R. (2005). Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Annals of Surgical Oncology, 12(6), 429-439. [More Information]
  • Saw, R., Morgan, M., Koorey, D., Painter, D., Findlay, M., Stevens, G., Clarke, S., Chapuis, P., Solomon, M. (2003). P53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Diseases of the Colon and Rectum, 46(2), 192-202. [More Information]
  • Saw, R., Koorey, D., Painter, D., Gallagher, P., Solomon, M. (2002). P53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. British Journal of Surgery, 89(11), 1409-1415.

Patents

  • Thompson, J., Armstrong, B., Barbour, A., Barnetson, R., Beanland, H., Beer, T., Brookshank, M., Burmeister, B., Butow, P., Clark, K., Conway, R., Damian, D., Frommer, M., Kefford, R., Lee, S., Mason, R., Mann, G., McCarthy, W., Menzies, S., Olver, I., Quinn, M., Saw, R., Shaw, H., Stretch, J., Barraclough, B., Holt, P., Reeve, T., et al (2008).

2014

  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R., Scolyer, R., Thompson, J. (2014). Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution. Annals of Surgery, 260(1), 149-157. [More Information]
  • Damian, D., Saw, R., Thompson, J. (2014). Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma. Journal of Surgical Oncology, 109(4), 308-313. [More Information]

2013

  • Carlino, M., Gowrishankar, K., Saunders, C., Pupo, G., Snoyman, S., Zhang, X., Saw, R., Becker, T., Kefford, R., Long, G., Rizos, H. (2013). Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition Following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma. Molecular Cancer Therapeutics, 12(7), 1332-1342. [More Information]
  • Harish, V., Bond, J., Scolyer, R., Haydu, L., Saw, R., Quinn, M., Benger, R., Uren, R., Stretch, J., Shannon, K., Thompson, J. (2013). Margins of excision and prognostic factors for cutaneous eyelid melanomas. Journal of Plastic, Reconstructive and Aesthetic Surgery (Print Edition), 66(8), 1066-1073. [More Information]
  • Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013). The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research, 23(1), 61-69. [More Information]
  • Pasquali, S., Haydu, L., Scolyer, R., Winstanley, J., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2013). The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas. Annals of Surgery, 258(1), 152-157. [More Information]

2012

  • Murali, R., Haydu, L., Long, G., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Kefford, R., Thompson, J., Scolyer, R. (2012). Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgical Oncology, 19(6), 1782-1789. [More Information]
  • Spillane, A., Haydu, L., Lee, N., Uren, R., Stretch, J., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2012). Evaluation of Incomplete Sentinel Node Biopsy Procedures and Sentinel Node Positivity Rates as Surgical Quality-Assurance Parameters in Melanoma Patients. Annals of Surgical Oncology, 19(12), 3919-3925. [More Information]
  • Murali, R., Haydu, L., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma. Annals of Surgery, 255(1), 128-133. [More Information]
  • Pasquali, S., Spillane, A., de Wilt, J., McCaffery, K., Rossi, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2012). Surgeons' Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey. Annals of Surgical Oncology, 19(13), 4322-4329. [More Information]
  • Martin, R., Shannon, K., Quinn, M., Saw, R., Spillane, A., Stretch, J., Colman, M., Gao, K., Thompson, J. (2012). The Management of Cervical Lymph Nodes in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 19(12), 3926-3932. [More Information]
  • Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S., Saw, R., Thompson, J. (2012). Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology, 30(21), 2678-2683. [More Information]

2011

  • Damian, D., Saw, R. (2011). Dramatic regression of cutaneous, nodal, and visceral melanoma metastases. Journal Of The American Academy Of Dermatology, 65(3), 665-666. [More Information]

2009

  • Spillane, A., Cheung, B., Stretch, J., Scolyer, R., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2009). Proposed quality standards for regional lymph node dissections in patients with melanoma. Annals of Surgery, 249(3), 473-480. [More Information]
  • Mocellin, S., Thompson, J., Pasquali, S., Montesco, M., Pilati, P., Nitti, D., Saw, R., Scolyer, R., Stretch, J., Rossi, C. (2009). Sentinel Node Status Prediction by Four Statistical Models Results From a Large Bi-Institutional Series (n=1132). Annals of Surgery, 250(6), 964-969. [More Information]

2008

  • Thompson, J., Armstrong, B., Barbour, A., Barnetson, R., Beanland, H., Beer, T., Brookshank, M., Burmeister, B., Butow, P., Clark, K., Conway, R., Damian, D., Frommer, M., Kefford, R., Lee, S., Mason, R., Mann, G., McCarthy, W., Menzies, S., Olver, I., Quinn, M., Saw, R., Shaw, H., Stretch, J., Barraclough, B., Holt, P., Reeve, T., et al (2008).
  • Spillane, A., Saw, R., Tucker, M., Byth Wilson, K., Thompson, J. (2008). Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Annals of Surgery, 248(2), 286-293. [More Information]
  • Doubrovsky, A., Scolyer, R., Murali, R., McKenzie, P., Watson, G., Lee, C., McLeod, D., McCarthy, W., Uren, R., Stretch, J., Saw, R., Thompson, J. (2008). Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. Annals of Surgical Oncology, 15(1), 323-332. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Guidelines for imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 877-879. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 847-876. [More Information]
  • Moncrieff, M., Bowen, F., Thompson, J., Saw, R., Shannon, K., Spillane, A., Quinn, M., Stretch, J. (2008). Keystone Flap Reconstruction of Primary Melanoma Excision Defects of the Leg-The End of the Skin Graft. Annals of Surgical Oncology, 15(10), 2867-2873. [More Information]

2007

  • Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Lee, C., McLeod, D., Uren, R., Stretch, J., Saw, R., Thompson, J., Scolyer, R. (2007). Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. American Journal of Clinical Pathology, 127(3), 385. [More Information]
  • Saw, R., Kam, P., Thompson, J. (2007). Isolated locoregional drug infusion for advanced and recurrent limb cancer: indications, techniques and results. Regional Oncotherapies, (pp. 177-191). Greece: Paschalidis Medical Publications.

2005

  • van Poll, D., Thompson, J., Colman, M., McKinnon, J., Saw, R., Stretch, J., Scolyer, R., Uren, R. (2005). A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(8), 597-608. [More Information]
  • Thompson, J., Saw, R., Stretch, J. (2005). Current strategies for the surgical management of melanoma. Cancer Forum, 29(2), 81-86.
  • Yee, V., Thompson, J., McKinnon, J., Scolyer, R., Li, L., McCarthy, W., O'Brien, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R. (2005). Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Annals of Surgical Oncology, 12(6), 429-439. [More Information]

2003

  • Saw, R., Morgan, M., Koorey, D., Painter, D., Findlay, M., Stevens, G., Clarke, S., Chapuis, P., Solomon, M. (2003). P53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Diseases of the Colon and Rectum, 46(2), 192-202. [More Information]

2002

  • Saw, R., Koorey, D., Painter, D., Gallagher, P., Solomon, M. (2002). P53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. British Journal of Surgery, 89(11), 1409-1415.

To update your profile click here. For support on your academic profile contact .